SCHEMBL22470198

SCHEMBL22470198

O=C(NO)C1CCN(CCNCc2ccccc2)CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DPP7 Q9UHL4 1/20 0.58
CARM1 Q86X55 1/20 0.53
PRMT6 Q96LA8 1/20 0.53
NPSR1 Q6W5P4 1/20 0.50
TSHR P16473 2/20 0.48
POLB P06746 1/20 0.48
CYP2D6 P10635 1/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
HDAC3 O15379 1/20 0.48
HDAC4 P56524 1/20 0.48
HDAC1 Q13547 1/20 0.48
HDAC7 Q8WUI4 1/20 0.48
HDAC2 Q92769 1/20 0.48
HDAC10 Q969S8 1/20 0.48
HDAC11 Q96DB2 1/20 0.48
HDAC8 Q9BY41 1/20 0.48
HDAC6 Q9UBN7 1/20 0.48
HDAC9 Q9UKV0 1/20 0.48
HDAC5 Q9UQL6 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22470207 0.88 DRD2 (0.45) DPP7CARM1PRMT6MEN1KMT2A
SCHEMBL7411682 0.83 HTR2A (0.68) HDAC1HDAC8HDAC6HTR2A
SCHEMBL22470262 0.81 DPP7 (0.49) DPP7CARM1PRMT6NPSR1TSHR
SCHEMBL22470259 0.81 ALDH1A1 (0.62) TSHRPOLBCYP2D6MEN1KMT2A
SCHEMBL22470297 0.80 MEN1 (0.62) TSHRMEN1KMT2AHDAC8GAA
SCHEMBL22470263 0.77 CARM1 (0.42) DPP7CARM1PRMT6KMT2ALTA4H
SCHEMBL3938078 0.77 NPSR1 (0.61) CARM1PRMT6NPSR1TSHRHTR2A
SCHEMBL3929082 0.76 NPSR1 (0.67) NPSR1TSHRHTR2AGAA
SCHEMBL5359200 0.75 DPP7 (0.60) DPP7CARM1PRMT6CYP2D6MEN1
SCHEMBL5756091 0.75 DPP7 (1.00) DPP7CYP2D6MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220151962-A1 NOVEL INHIBITORS OF HISTONE DEACETYLASE 10 DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) 2022-05-19 US disclosed
US-20220151962-A1 NOVEL INHIBITORS OF HISTONE DEACETYLASE 10 DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) 2022-05-19 US disclosed
EP-3941900-A1 NOVEL INHIBITORS OF HISTONE DEACETYLASE 10 Deutsches Krebsforschungszentrum (DE) 2022-01-26 EP disclosed
WO-2020193431-A1 NOVEL INHIBITORS OF HISTONE DEACETYLASE 10 DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) 2020-10-01 WO disclosed
WO-2020193431-A1 NOVEL INHIBITORS OF HISTONE DEACETYLASE 10 DEUTSCHES KREBSFORSCHUNGSZENTRUM (DE) 2020-10-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220151962-A1 NOVEL INHIBITORS OF HISTONE DEACETYLASE 10 HDAC10, HDAC1, HDAC11 DPP7 664/4885CARM1 207/4885PRMT6 811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.